nodes	percent_of_prediction	percent_of_DWPC	metapath
Methohexital—Laryngospasm—Etoposide—peripheral nervous system neoplasm	0.0198	0.0198	CcSEcCtD
Methohexital—Apnoea—Etoposide—peripheral nervous system neoplasm	0.0174	0.0174	CcSEcCtD
Methohexital—Liver function test abnormal—Melphalan—peripheral nervous system neoplasm	0.0165	0.0165	CcSEcCtD
Methohexital—Hiccups—Cisplatin—peripheral nervous system neoplasm	0.0161	0.0161	CcSEcCtD
Methohexital—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.0154	0.0154	CcSEcCtD
Methohexital—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.0154	0.0154	CcSEcCtD
Methohexital—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.0152	0.0152	CcSEcCtD
Methohexital—Liver function test abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0137	0.0137	CcSEcCtD
Methohexital—Rhinitis—Topotecan—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Methohexital—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Methohexital—Erythema—Tretinoin—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Methohexital—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Methohexital—Injection site pain—Epirubicin—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Methohexital—Agitation—Tretinoin—peripheral nervous system neoplasm	0.01	0.01	CcSEcCtD
Methohexital—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.01	0.01	CcSEcCtD
Methohexital—Delirium—Epirubicin—peripheral nervous system neoplasm	0.00961	0.00961	CcSEcCtD
Methohexital—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00944	0.00944	CcSEcCtD
Methohexital—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00944	0.00944	CcSEcCtD
Methohexital—Injection site pain—Doxorubicin—peripheral nervous system neoplasm	0.00937	0.00937	CcSEcCtD
Methohexital—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00932	0.00932	CcSEcCtD
Methohexital—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00925	0.00925	CcSEcCtD
Methohexital—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00925	0.00925	CcSEcCtD
Methohexital—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.0091	0.0091	CcSEcCtD
Methohexital—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00897	0.00897	CcSEcCtD
Methohexital—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00891	0.00891	CcSEcCtD
Methohexital—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.0089	0.0089	CcSEcCtD
Methohexital—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.0089	0.0089	CcSEcCtD
Methohexital—Delirium—Doxorubicin—peripheral nervous system neoplasm	0.00889	0.00889	CcSEcCtD
Methohexital—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00878	0.00878	CcSEcCtD
Methohexital—Shock—Tretinoin—peripheral nervous system neoplasm	0.00875	0.00875	CcSEcCtD
Methohexital—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00875	0.00875	CcSEcCtD
Methohexital—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00868	0.00868	CcSEcCtD
Methohexital—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00868	0.00868	CcSEcCtD
Methohexital—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00857	0.00857	CcSEcCtD
Methohexital—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00831	0.00831	CcSEcCtD
Methohexital—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00831	0.00831	CcSEcCtD
Methohexital—Hiccups—Epirubicin—peripheral nervous system neoplasm	0.00827	0.00827	CcSEcCtD
Methohexital—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00826	0.00826	CcSEcCtD
Methohexital—Hypotension—Melphalan—peripheral nervous system neoplasm	0.0082	0.0082	CcSEcCtD
Methohexital—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.00803	0.00803	CcSEcCtD
Methohexital—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00799	0.00799	CcSEcCtD
Methohexital—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00793	0.00793	CcSEcCtD
Methohexital—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00793	0.00793	CcSEcCtD
Methohexital—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00783	0.00783	CcSEcCtD
Methohexital—Hiccups—Doxorubicin—peripheral nervous system neoplasm	0.00765	0.00765	CcSEcCtD
Methohexital—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00759	0.00759	CcSEcCtD
Methohexital—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00743	0.00743	CcSEcCtD
Methohexital—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00733	0.00733	CcSEcCtD
Methohexital—Agitation—Vincristine—peripheral nervous system neoplasm	0.00731	0.00731	CcSEcCtD
Methohexital—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00727	0.00727	CcSEcCtD
Methohexital—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00727	0.00727	CcSEcCtD
Methohexital—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00716	0.00716	CcSEcCtD
Methohexital—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00712	0.00712	CcSEcCtD
Methohexital—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00709	0.00709	CcSEcCtD
Methohexital—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00707	0.00707	CcSEcCtD
Methohexital—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00707	0.00707	CcSEcCtD
Methohexital—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00704	0.00704	CcSEcCtD
Methohexital—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00703	0.00703	CcSEcCtD
Methohexital—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00703	0.00703	CcSEcCtD
Methohexital—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00701	0.00701	CcSEcCtD
Methohexital—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00698	0.00698	CcSEcCtD
Methohexital—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.00693	0.00693	CcSEcCtD
Methohexital—Convulsion—Vincristine—peripheral nervous system neoplasm	0.0069	0.0069	CcSEcCtD
Methohexital—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00674	0.00674	CcSEcCtD
Methohexital—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00663	0.00663	CcSEcCtD
Methohexital—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00658	0.00658	CcSEcCtD
Methohexital—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.0065	0.0065	CcSEcCtD
Methohexital—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00641	0.00641	CcSEcCtD
Methohexital—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00634	0.00634	CcSEcCtD
Methohexital—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.0063	0.0063	CcSEcCtD
Methohexital—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00629	0.00629	CcSEcCtD
Methohexital—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00629	0.00629	CcSEcCtD
Methohexital—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00621	0.00621	CcSEcCtD
Methohexital—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.0061	0.0061	CcSEcCtD
Methohexital—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00607	0.00607	CcSEcCtD
Methohexital—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00601	0.00601	CcSEcCtD
Methohexital—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00597	0.00597	CcSEcCtD
Methohexital—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00595	0.00595	CcSEcCtD
Methohexital—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00575	0.00575	CcSEcCtD
Methohexital—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00574	0.00574	CcSEcCtD
Methohexital—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0057	0.0057	CcSEcCtD
Methohexital—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00566	0.00566	CcSEcCtD
Methohexital—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00566	0.00566	CcSEcCtD
Methohexital—Headache—Topotecan—peripheral nervous system neoplasm	0.00562	0.00562	CcSEcCtD
Methohexital—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00561	0.00561	CcSEcCtD
Methohexital—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00559	0.00559	CcSEcCtD
Methohexital—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00558	0.00558	CcSEcCtD
Methohexital—Headache—Tretinoin—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Methohexital—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Methohexital—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00554	0.00554	CcSEcCtD
Methohexital—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00551	0.00551	CcSEcCtD
Methohexital—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00537	0.00537	CcSEcCtD
Methohexital—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00536	0.00536	CcSEcCtD
Methohexital—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00533	0.00533	CcSEcCtD
Methohexital—Nausea—Topotecan—peripheral nervous system neoplasm	0.00533	0.00533	CcSEcCtD
Methohexital—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00531	0.00531	CcSEcCtD
Methohexital—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00528	0.00528	CcSEcCtD
Methohexital—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00528	0.00528	CcSEcCtD
Methohexital—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00526	0.00526	CcSEcCtD
Methohexital—Nausea—Melphalan—peripheral nervous system neoplasm	0.00522	0.00522	CcSEcCtD
Methohexital—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00514	0.00514	CcSEcCtD
Methohexital—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00514	0.00514	CcSEcCtD
Methohexital—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00513	0.00513	CcSEcCtD
Methohexital—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00512	0.00512	CcSEcCtD
Methohexital—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00492	0.00492	CcSEcCtD
Methohexital—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00477	0.00477	CcSEcCtD
Methohexital—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00469	0.00469	CcSEcCtD
Methohexital—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00462	0.00462	CcSEcCtD
Methohexital—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Methohexital—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.0043	0.0043	CcSEcCtD
Methohexital—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00429	0.00429	CcSEcCtD
Methohexital—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00422	0.00422	CcSEcCtD
Methohexital—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00418	0.00418	CcSEcCtD
Methohexital—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00416	0.00416	CcSEcCtD
Methohexital—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00416	0.00416	CcSEcCtD
Methohexital—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00413	0.00413	CcSEcCtD
Methohexital—Headache—Vincristine—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Methohexital—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Methohexital—Nausea—Vincristine—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Methohexital—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00385	0.00385	CcSEcCtD
Methohexital—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00372	0.00372	CcSEcCtD
Methohexital—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00365	0.00365	CcSEcCtD
Methohexital—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Methohexital—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Methohexital—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00335	0.00335	CcSEcCtD
Methohexital—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Methohexital—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Methohexital—Headache—Etoposide—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Methohexital—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Methohexital—Nausea—Etoposide—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Methohexital—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Methohexital—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Methohexital—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Methohexital—Shock—Epirubicin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Methohexital—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Methohexital—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Methohexital—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Methohexital—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Methohexital—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Methohexital—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Methohexital—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Methohexital—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Methohexital—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Methohexital—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Methohexital—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Methohexital—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Methohexital—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Methohexital—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Methohexital—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Methohexital—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Methohexital—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Methohexital—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Methohexital—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Methohexital—Headache—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Methohexital—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Methohexital—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Methohexital—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Methohexital—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
